Stryker Corporation (NYSE:SYK) has been assigned a consensus recommendation of “Hold” from the twenty-two brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $144.03.
Several analysts have recently weighed in on SYK shares. BMO Capital Markets restated a “hold” rating and issued a $140.00 price objective on shares of Stryker Corporation in a report on Tuesday, July 11th. Oppenheimer Holdings, Inc. restated a “hold” rating on shares of Stryker Corporation in a report on Monday, June 19th. Citigroup Inc. upped their price objective on Stryker Corporation from $114.00 to $125.00 and gave the company a “sell” rating in a report on Friday, June 9th. Cantor Fitzgerald started coverage on Stryker Corporation in a report on Thursday, June 29th. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Morgan Stanley restated an “overweight” rating and issued a $160.00 price objective (up previously from $155.00) on shares of Stryker Corporation in a report on Monday, July 10th.
In other Stryker Corporation news, insider David Floyd sold 19,305 shares of the company’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold 31,686 shares of company stock worth $4,590,562 over the last three months. 7.40% of the stock is owned by insiders.
Shares of Stryker Corporation (NYSE SYK) traded down 0.40% on Tuesday, hitting $146.14. The stock had a trading volume of 644,974 shares. The firm has a market cap of $54.67 billion, a P/E ratio of 32.62 and a beta of 0.80. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $148.84. The company’s 50-day moving average price is $143.16 and its 200 day moving average price is $134.68.
Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.39 earnings per share. On average, equities research analysts forecast that Stryker Corporation will post $6.50 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be given a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
What are top analysts saying about Stryker Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stryker Corporation and related companies.